DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
29 feb 2012 - 07:27
Statutaire naam
DSM B.V.
Titel
DSM reports another strong year and increases dividend
Bericht
Q4 EBITDA from continuing operations up 6% to €293 million
Full year EBITDA from continuing operations increased 12% to €1,296 million
Life Sciences delivered further EBITDA growth through Nutrition
Materials Sciences posted a strong year with record Polymer Intermediates results
Good strategic progress with Martek acquisition and joint venture with Sinochem
EPS (before exceptional items, continuing operations) up 22% to €3.53
Dividend increase by €0.10 to €1.45 per ordinary share proposed for 2011
Cautiously optimistic outlook, on the way to achieve 2013 targets
Datum laatste update: 01 september 2024